Bronchiolar Complications of Connective Tissue Diseases

Eric S. White, Henry D. Tazelaar, Joseph P. Lynch

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Inflammatory and fibrotic processes can involve the small airways (i.e., respiratory and terminal bronchioles) in several connective tissue disorders (CTDs). Obliterative (constrictive) bronchiolitis (OB) as well cryptogenic organizing pneumonia (COP), previously termed bronchiolitis obliterans with organizing pneumonia (BOOP), are well-recognized, albeit rare, complications of rheumatoid arthritis and other CTDS. Bronchiectasis has also been described in patients with CTDs. Among the various pathologic conditions, clinical, radiographic, and histologic features and prognosis differ markedly. Clinical features are often nonspecific, and sometimes patients may be asymptomatic. Diagnosing these disorders may be difficult. High-resolution computed tomography (HRCT) is useful in detecting bronchiolar pathology, even when symptoms are minimal or absent. Surgical (open or thoracoscopic) lung biopsies can substantiate the diagnosis, but in some cases, the diagnosis can be affirmed less aggressively by appropriate imaging studies (e.g., HRCT) and transbronchial lung biopsies. Corticosteroids are highly efficacious for COP, but therapeutic options for OB are disappointing. Prophylactic antibiotics and good pulmonary hygiene remain the mainstay of therapy for patients with bronchiectasis.

Original languageEnglish (US)
Pages (from-to)543-565
Number of pages23
JournalSeminars in Respiratory and Critical Care Medicine
Volume24
Issue number5
DOIs
StatePublished - Oct 2003

Fingerprint

Cryptogenic Organizing Pneumonia
Connective Tissue Diseases
Bronchiolitis Obliterans
Bronchioles
Bronchiectasis
Connective Tissue
Lung
Tomography
Biopsy
Hygiene
Rheumatoid Arthritis
Adrenal Cortex Hormones
Pathology
Anti-Bacterial Agents
Therapeutics

Keywords

  • Airflow obstruction
  • Bronchiolitis
  • Bronchiolitis obliterans-organizing pneumonia
  • Connective tissue diseases
  • Constrictive bronchiolitis
  • Cryptogenic organizing pneumonia
  • Obliterative bronchiolitis
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Critical Care

Cite this

Bronchiolar Complications of Connective Tissue Diseases. / White, Eric S.; Tazelaar, Henry D.; Lynch, Joseph P.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 24, No. 5, 10.2003, p. 543-565.

Research output: Contribution to journalArticle

White, Eric S. ; Tazelaar, Henry D. ; Lynch, Joseph P. / Bronchiolar Complications of Connective Tissue Diseases. In: Seminars in Respiratory and Critical Care Medicine. 2003 ; Vol. 24, No. 5. pp. 543-565.
@article{a23ca43075be498a84ebe720f5f254fb,
title = "Bronchiolar Complications of Connective Tissue Diseases",
abstract = "Inflammatory and fibrotic processes can involve the small airways (i.e., respiratory and terminal bronchioles) in several connective tissue disorders (CTDs). Obliterative (constrictive) bronchiolitis (OB) as well cryptogenic organizing pneumonia (COP), previously termed bronchiolitis obliterans with organizing pneumonia (BOOP), are well-recognized, albeit rare, complications of rheumatoid arthritis and other CTDS. Bronchiectasis has also been described in patients with CTDs. Among the various pathologic conditions, clinical, radiographic, and histologic features and prognosis differ markedly. Clinical features are often nonspecific, and sometimes patients may be asymptomatic. Diagnosing these disorders may be difficult. High-resolution computed tomography (HRCT) is useful in detecting bronchiolar pathology, even when symptoms are minimal or absent. Surgical (open or thoracoscopic) lung biopsies can substantiate the diagnosis, but in some cases, the diagnosis can be affirmed less aggressively by appropriate imaging studies (e.g., HRCT) and transbronchial lung biopsies. Corticosteroids are highly efficacious for COP, but therapeutic options for OB are disappointing. Prophylactic antibiotics and good pulmonary hygiene remain the mainstay of therapy for patients with bronchiectasis.",
keywords = "Airflow obstruction, Bronchiolitis, Bronchiolitis obliterans-organizing pneumonia, Connective tissue diseases, Constrictive bronchiolitis, Cryptogenic organizing pneumonia, Obliterative bronchiolitis, Rheumatoid arthritis",
author = "White, {Eric S.} and Tazelaar, {Henry D.} and Lynch, {Joseph P.}",
year = "2003",
month = "10",
doi = "10.1055/s-2004-815603",
language = "English (US)",
volume = "24",
pages = "543--565",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "5",

}

TY - JOUR

T1 - Bronchiolar Complications of Connective Tissue Diseases

AU - White, Eric S.

AU - Tazelaar, Henry D.

AU - Lynch, Joseph P.

PY - 2003/10

Y1 - 2003/10

N2 - Inflammatory and fibrotic processes can involve the small airways (i.e., respiratory and terminal bronchioles) in several connective tissue disorders (CTDs). Obliterative (constrictive) bronchiolitis (OB) as well cryptogenic organizing pneumonia (COP), previously termed bronchiolitis obliterans with organizing pneumonia (BOOP), are well-recognized, albeit rare, complications of rheumatoid arthritis and other CTDS. Bronchiectasis has also been described in patients with CTDs. Among the various pathologic conditions, clinical, radiographic, and histologic features and prognosis differ markedly. Clinical features are often nonspecific, and sometimes patients may be asymptomatic. Diagnosing these disorders may be difficult. High-resolution computed tomography (HRCT) is useful in detecting bronchiolar pathology, even when symptoms are minimal or absent. Surgical (open or thoracoscopic) lung biopsies can substantiate the diagnosis, but in some cases, the diagnosis can be affirmed less aggressively by appropriate imaging studies (e.g., HRCT) and transbronchial lung biopsies. Corticosteroids are highly efficacious for COP, but therapeutic options for OB are disappointing. Prophylactic antibiotics and good pulmonary hygiene remain the mainstay of therapy for patients with bronchiectasis.

AB - Inflammatory and fibrotic processes can involve the small airways (i.e., respiratory and terminal bronchioles) in several connective tissue disorders (CTDs). Obliterative (constrictive) bronchiolitis (OB) as well cryptogenic organizing pneumonia (COP), previously termed bronchiolitis obliterans with organizing pneumonia (BOOP), are well-recognized, albeit rare, complications of rheumatoid arthritis and other CTDS. Bronchiectasis has also been described in patients with CTDs. Among the various pathologic conditions, clinical, radiographic, and histologic features and prognosis differ markedly. Clinical features are often nonspecific, and sometimes patients may be asymptomatic. Diagnosing these disorders may be difficult. High-resolution computed tomography (HRCT) is useful in detecting bronchiolar pathology, even when symptoms are minimal or absent. Surgical (open or thoracoscopic) lung biopsies can substantiate the diagnosis, but in some cases, the diagnosis can be affirmed less aggressively by appropriate imaging studies (e.g., HRCT) and transbronchial lung biopsies. Corticosteroids are highly efficacious for COP, but therapeutic options for OB are disappointing. Prophylactic antibiotics and good pulmonary hygiene remain the mainstay of therapy for patients with bronchiectasis.

KW - Airflow obstruction

KW - Bronchiolitis

KW - Bronchiolitis obliterans-organizing pneumonia

KW - Connective tissue diseases

KW - Constrictive bronchiolitis

KW - Cryptogenic organizing pneumonia

KW - Obliterative bronchiolitis

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=0347381242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347381242&partnerID=8YFLogxK

U2 - 10.1055/s-2004-815603

DO - 10.1055/s-2004-815603

M3 - Article

C2 - 16088572

AN - SCOPUS:0347381242

VL - 24

SP - 543

EP - 565

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 5

ER -